Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
  Home Print this page Email this page Small font sizeDefault font sizeIncrease font size Users Online: 436  
REVIEW ARTICLE
Year : 2020  |  Volume : 19  |  Issue : 3  |  Page : 187-196

Role of18F-fluorodeoxyglucose positron emission tomography/computed tomography in the evaluation of breast carcinoma: Indications and pitfalls with illustrative case examples


1 Department of Radiology, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia
2 Department of Cyclotron and Radiopharmaceuticals, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia

Correspondence Address:
Dr. Moheieldin M Abouzied
Department of Radiology, King Faisal Specialist Hospital and Research Centre, Riyadh
Saudi Arabia
Login to access the Email id


DOI: 10.4103/wjnm.WJNM_88_19

Rights and Permissions

Whole-body18F-fluorodeoxyglucose positron emission tomography (PET) has been used extensively in the last decade for the primary staging and restaging and to assess response to therapy in these patients. We aim to discuss the diagnostic performance of PET/computed tomography in the initial staging of breast carcinoma including the locally advanced disease and to illustrate its role in restaging the disease and in the assessment of response to therapy, particularly after the neoadjuvant chemotherapy. Causes of common pitfalls during image interpretations will be also discussed.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed249    
    Printed16    
    Emailed0    
    PDF Downloaded74    
    Comments [Add]    

Recommend this journal